Previous close | 28.20 |
Open | N/A |
Bid | 34.10 |
Ask | 38.80 |
Strike | 95.00 |
Expiry date | 2024-06-21 |
Day's range | 28.20 - 28.20 |
Contract range | N/A |
Volume | |
Open interest | N/A |
WILMINGTON, Del., May 02, 2024--Incyte (Nasdaq:INCY) announced today that it will present at the Bank of America Securities 2024 Health Care Conference on Wednesday, May 15, 2024 at 8:00 a.m. (PDT) in Las Vegas.
Incyte Corporation (NASDAQ:INCY) Q1 2024 Earnings Call Transcript April 30, 2024 Incyte Corporation misses on earnings expectations. Reported EPS is $0.746 EPS, expectations were $0.88. INCY isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello and welcome to Incyte First […]
Incyte's (INCY) first-quarter 2024 earnings and revenues miss estimates. The company maintains 2024 revenue guidance for its lead drug, Jakafi.